On Invalid Date, Pfizer (NYSE: PFE) reported Q4 2023 earnings per share (EPS) of -$0.59, up 167.05% year over year. Total Pfizer earnings for the quarter were -$3.37 billion. In the same quarter last year, Pfizer's earnings per share (EPS) was $0.88.
As of Q2 2024, Pfizer's earnings has grown -93.2% year over year. This is 110.53 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 17.33%. Pfizer's earnings in the past year totalled $2.12 billion.
What was PFE's revenue last quarter?
On Invalid Date, Pfizer (NYSE: PFE) reported Q4 2023 revenue of $14.25 billion up 41.34% year over year. In the same quarter last year, Pfizer's revenue was $24.29 billion.
What was PFE's revenue growth in the past year?
As of Q2 2024, Pfizer's revenue has grown -41.7% year over year. This is 50.65 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 8.96%. Pfizer's revenue in the past year totalled $58.50 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.